Role of genetic polymorphisms and ovarian cancer susceptibility

@article{Fasching2009RoleOG,
  title={Role of genetic polymorphisms and ovarian cancer susceptibility},
  author={P. Fasching and S. Gayther and L. Pearce and J. Schildkraut and E. Goode and F. Thiel and G. Chenevix-Trench and J. Chang-Claude and S. Wang-Gohrke and S. Ramus and P. Pharoah and A. Berchuck},
  journal={Molecular Oncology},
  year={2009},
  volume={3}
}
  • P. Fasching, S. Gayther, +9 authors A. Berchuck
  • Published 2009
  • Medicine
  • Molecular Oncology
  • The value of identifying women with an inherited predisposition to epithelial ovarian cancer has become readily apparent with the identification of the BRCA1, and BRCA2 genes. Women who inherit a deleterious mutation in either of these genes have a very high lifetime risk of ovarian cancer (10–60%) and to some extent, increased risks of fallopian tube and peritoneal cancer. These highly lethal cancers are almost completely prevented by prophylactic salpingoophorectomy. BRCA1/2 mutation testing… CONTINUE READING
    76 Citations
    The inherited genetics of ovarian and endometrial cancer.
    • 56
    Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.
    • 37
    • PDF

    References

    SHOWING 1-10 OF 77 REFERENCES
    No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.
    • 79
    Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.
    • T. Frank, S. A. Manley, +22 authors A. Thomas
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1998
    • 455
    Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.
    • H. Risch
    • Biology, Medicine
    • Journal of the National Cancer Institute
    • 1998
    • 758
    • PDF